Avinger Inc (AVGR) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Avinger Inc (AVGR) has a cash flow conversion efficiency ratio of -0.738x as of September 2024. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-2.86 Million) by net assets ($3.88 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See AVGR days of operational coverage to measure how many days the company can operate on defensive assets alone.
Avinger Inc - Cash Flow Conversion Efficiency Trend (2012–2023)
This chart illustrates how Avinger Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Avinger Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Avinger Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
ProAm Explorations Corp
V:PMX
|
0.370x |
|
Central China Real Estate Limited
F:AJ5
|
-0.088x |
|
RIDGESTONE MINING INC.
F:4U50
|
0.006x |
|
Ortin Global Limited
NSE:ORTINGLOBE
|
-0.627x |
|
Vastra Hamnens Restaurangdrift Ab
ST:VH
|
0.050x |
|
INCUVO S.A. ZY -50
F:68X
|
0.135x |
|
Yida China Holdings Ltd
STU:YC2
|
N/A |
|
BBS-Bioactive Bone Substitutes Oyj
HE:BONEH
|
-0.416x |
Annual Cash Flow Conversion Efficiency for Avinger Inc (2012–2023)
The table below shows the annual cash flow conversion efficiency of Avinger Inc from 2012 to 2023. For the full company profile with market capitalisation and key ratios, see Avinger Inc (AVGR) total market value.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2023-12-31 | $-6.20 Million | $-14.43 Million | 2.327x | +157.56% |
| 2022-12-31 | $4.15 Million | $-16.76 Million | -4.042x | -150.40% |
| 2021-12-31 | $9.72 Million | $-15.70 Million | -1.614x | -42.30% |
| 2020-12-31 | $13.08 Million | $-14.84 Million | -1.135x | +54.69% |
| 2019-12-31 | $6.89 Million | $-17.26 Million | -2.504x | -28.27% |
| 2018-12-31 | $9.46 Million | $-18.47 Million | -1.952x | -302.07% |
| 2017-12-31 | $-35.69 Million | $-34.48 Million | 0.966x | +107.72% |
| 2016-12-31 | $4.24 Million | $-53.07 Million | -12.513x | -377.14% |
| 2015-12-31 | $15.59 Million | $-40.88 Million | -2.623x | -1830.66% |
| 2014-12-31 | $-143.87 Million | $-21.80 Million | 0.152x | -57.96% |
| 2013-12-31 | $-112.78 Million | $-40.66 Million | 0.360x | -24.66% |
| 2012-12-31 | $-73.64 Million | $-35.23 Million | 0.478x | -- |
About Avinger Inc
Avinger, Inc., a commercial-stage medical device company, designs, manufactures, and sells a suite of image-guided and catheter-based systems used by physicians to treat patients with peripheral artery disease (PAD) primarily in the United States and Germany. The company develops lumivascular platform that integrates optical coherence tomography visualization with interventional catheters to prov… Read more